Xiao Linxiao, Zou Xuelun, Liang Yan, Wang Yuxiang, Zeng Lang, Wu Jianhuang
Department of Spine Surgery and Orthopaedics, Xiangya Hospital, Central South University, Changsha, China.
Department of Neurology, Xiangya Hospital, Central South University, Changsha, China.
Front Genet. 2022 Apr 4;13:838809. doi: 10.3389/fgene.2022.838809. eCollection 2022.
Since tissue inhibitors of matrix metalloproteinase 3 (TIMP-3) was reported to be a potential risk factor of atherosclerosis, aneurysm, hypertension, and post-ischaemic neuronal injury, it may also be a candidate risk factor of stress. Therefore, this study was designed to explore the causal role of TIMP-3 in the risk of ischaemic stroke (IS) and intracerebral haemorrhage (ICH), which are the two main causes of stress via this Mendelian Randomisation (MR) study. The summarised data of TIMP-3 level in circulation was acquired from the Cooperative Health Research in the Region of Augsburg public database and the outcome of IS and ICH was obtained from genome-wide association studies conducted by MEGASTROKE and the International Stroke Genetics Consortium, respectively. Five statistical methods including inverse-variance weighting, weighted-median analysis, MR-Egger regression, MR Pleiotropy RESidual Sum and Outlier test, and MR-Robust Adjusted Profile Score were applied to evaluate the causal role of TIMP-3 in the occurrence of IS and ICH. Inverse-variance weighting was applied for assessing causality. Furthermore, heterogeneity and pleiotropic tests were utilised to confirm the reliability of this study. We found that TIMP-3 could be a positively causal relationship with the incidence of IS (OR = 1.026, 95% CI: 1.007-1.046, = 0.0067), especially for the occurrence of small vessel stroke (SVS; OR = 1.045, 95% CI: 1.016-1.076, = 0.0024). However, the causal effects of TIMP-3 on another IS subtype cardioembolic stroke (CES; OR = 1.049, 95% CI: 1.006-1.094, = 0.024), large artery stroke (LAS; OR = 1.0027, 95% CI: 0.9755-1.0306, = 0.849) and ICH (OR = 0.9900, 95% CI: 0.9403-1.0423, = 0.701), as well as ICH subtypes were not observed after Bonferroni corrections ( = 0.00714). Our results revealed that high levels of circulating TIMP-3 causally increased the risk of developing IS and SVS, but not CES, LAS, ICH, and all ICH subtypes. Further investigation is required to elucidate the underlying mechanism.
由于基质金属蛋白酶3组织抑制剂(TIMP-3)被报道为动脉粥样硬化、动脉瘤、高血压和缺血后神经元损伤的潜在危险因素,它也可能是应激的候选危险因素。因此,本研究旨在通过孟德尔随机化(MR)研究探索TIMP-3在缺血性卒中(IS)和脑出血(ICH)风险中的因果作用,而IS和ICH是应激的两个主要原因。循环中TIMP-3水平的汇总数据来自奥格斯堡地区合作健康研究公共数据库,IS和ICH的结果分别来自MEGASTROKE和国际卒中遗传学联盟进行的全基因组关联研究。应用包括逆方差加权、加权中位数分析、MR-Egger回归、MR多效性残差和离群值检验以及MR稳健调整轮廓得分在内的五种统计方法来评估TIMP-3在IS和ICH发生中的因果作用。采用逆方差加权评估因果关系。此外,利用异质性和多效性检验来确认本研究的可靠性。我们发现TIMP-3与IS的发生率可能存在正因果关系(OR = 1.026,95%CI:1.007 - 1.046,P = 0.0067),特别是对于小血管卒中(SVS)的发生(OR = 1.045,95%CI:1.016 - 1.076,P = 0.0024)。然而,在进行Bonferroni校正(P = 0.00714)后,未观察到TIMP-3对另一种IS亚型心源性栓塞性卒中(CES;OR = 1.049,95%CI:1.006 - 1.094,P = 0.024)、大动脉卒中(LAS;OR = 1.0027,95%CI:0.9755 - 1.0306,P = 0.849)和ICH(OR = 0.9900,95%CI:0.9403 - 1.0423,P = 0.701)以及ICH亚型的因果效应。我们的结果表明,循环中高水平的TIMP-3因果性地增加了发生IS和SVS的风险,但对CES、LAS、ICH以及所有ICH亚型没有影响。需要进一步研究以阐明其潜在机制。